[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100542156":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":45,"responsibleParty":62,"collaborators":64,"id":68,"slug":25,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":25,"eligibilityCriteria":73,"healthyVolunteers":69,"sex":74,"minAge":75,"maxAge":25,"enrollmentInfo":76,"targetDuration":25,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":25,"overallStatus":47,"whyStopped":25,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Loma Linda University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Irrisept","EXPERIMENTAL","The experimental arm will receive irrigation solution Irrisept administered through a proprietary bottle (jet lavage) following the closure of the fascia in Cesarean section.",[13],"Device: Irrisept",{"label":15,"type":16,"description":17,"interventionNames":18},"Normal Saline","ACTIVE_COMPARATOR","The active comparator arm will receive the standard of care irrigation solution, normal saline, administered via standard pour over following the closure of the fascia in Cesarean section.",[19],"Drug: Normal Saline",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","450ml low concentration (0.05%) Chlorhexidine Gluconate (CHG) in 99.95% Sterile Water",[9],null,{"type":27,"name":15,"description":28,"armGroupLabels":29,"otherNames":25},"DRUG","450mL",[15],[31],{"name":32,"affiliation":5,"role":33},"Ruofan Yao, MD, MPH","PRINCIPAL_INVESTIGATOR",[35,41],{"name":36,"role":37,"phone":38,"phoneExt":39,"email":40},"Nikia Gray-Hutto, AS","CONTACT","9095584000","44428","nhutto@llu.edu",{"name":42,"role":37,"phone":43,"phoneExt":25,"email":44},"Ashra Denise Tugung, BS","9096515580","atugung@llu.edu",[46],{"facility":5,"status":47,"city":48,"state":49,"zip":50,"country":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"RECRUITING","Loma Linda","California","92354","United States",{"type":53,"coordinates":54},"Point",[55,56],-117.26115,34.04835,{"lat":56,"lon":55},[59],{"name":60,"role":37,"phone":61,"phoneExt":39,"email":40},"Nikia Gray Hutto, AS","909-558-4000",{"type":63,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[65],{"name":66,"class":67},"Irrimax Corporation","INDUSTRY","100542156",false,"NCT06339203","Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)","Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section: a Randomized Clinical Trial (WISHES Study)","Inclusion Criteria:\n\n* Age 18 or older\n* Singleton pregnancy\n* Planned cesarean delivery at gestational age 37 weeks or later at Loma Linda University Children's Hospital\n* Planned post-operative follow up with Loma Linda OBGYN\n* Speak English or Spanish\n* At least one of the following medical complications: Obesity BMI\\>= 30kg\u002Fm2, Diabetes, Spontaneous rupture of membranes, Intraamniotic infection\n\nExclusion Criteria:\n\n* Emergency cesarean delivery","FEMALE","18 Years",{"count":77,"type":78},400,"ESTIMATED","INTERVENTIONAL",[81],"NA","This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in 99.95% sterile water for irrigation. The study aims to evaluate the impact on postoperative wound healing in patients who have undergone cesarean delivery.",[84,85],"Cesarean Section Complications","Cesarean Section; Infection","2026-06-05",{"date":88,"type":89},"2026-06-08","ACTUAL",{"date":91,"type":89},"2024-06-05",{"date":93,"type":78},"2026-12",{"name":5,"class":6},1]